We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+27.13%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$329M
AUM Growth
+$97.7M
Cap. Flow
+$49.2M
Cap. Flow %
14.96%
Top 10 Hldgs %
74.44%
Holding
53
New
6
Increased
33
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
CXRX
Concordia International Corp. Common Stock
CXRX
+$40.3M
2
QLTI
QLT Inc
QLTI
+$6.07M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$5.3M
4
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
+$3.1M
5
BSTC
BioSpecifics Technologies Corp.
BSTC
+$2.62M

Top Sells

Rank Stock Value
1
LCI
Lannett Company, Inc.
LCI
+$5.63M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$4.23M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$3.82M
4
TSLA icon
Tesla
TSLA
+$2.83M
5
AKRX
Akorn Inc
AKRX
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 76.88%
2 Technology 7.51%
3 Financials 5.1%
4 Consumer Discretionary 3.81%
5 Communication Services 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$66.1M 20.08%
816,884
+81,342
+11% +$5.3M
CXRX
2
DELISTED
Concordia International Corp. Common Stock
CXRX
$40.2M 12.23%
+557,500
New +$40.3M
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$26.6M 8.1%
766,724
+37,115
+5% +$1.13M
REGN icon
4
Regeneron Pharmaceuticals
REGN
$73.1B
$24.8M 7.54%
48,619
+1,281
+3% +$625K
AAPL icon
5
Apple
AAPL
$4.96T
$24.7M 7.51%
788,144
+68,144
+9% +$2.18M
BX icon
6
Blackstone
BX
$104B
$16.8M 5.1%
418,521
+10,435
+3% +$429K
INSY
7
DELISTED
Insys Therapeutics, Inc.
INSY
$13.8M 4.2%
384,644
+10,408
+3% +$324K
AGN
8
DELISTED
Allergan plc
AGN
$12.7M 3.85%
41,764
+1,170
+3% +$349K
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$12M 3.64%
564,525
+12,963
+2% +$232K
TARO
10
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$7.19M 2.19%
50,050
-29,635
-37% -$4.23M
BWLD
11
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$6.92M 2.1%
44,180
+852
+2% +$139K
PRGO icon
12
Perrigo
PRGO
$1.44B
$6.63M 2.01%
35,850
+8,819
+33% +$1.68M
QLTI
13
DELISTED
QLT Inc
QLTI
$6.58M 2%
1,592,993
+1,582,000
+14,391% +$6.07M
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$5.99M 1.82%
33,110
+881
+3% +$152K
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$16.1B
$5.85M 1.78%
33,246
+810
+2% +$145K
JNP
16
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$4.56M 1.39%
498,021
-746
-0.1% -$5.63K
KYTH
17
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$4.36M 1.33%
+57,925
New +$3.1M
LGND icon
18
Ligand Pharmaceuticals
LGND
$5.78B
$3.62M 1.1%
57,448
+1,313
+2% +$71.6K
BSTC
19
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.18M 0.97%
+61,557
New +$2.62M
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.71M 0.83%
111,630
+245
+0.2% +$5.87K
CMG icon
21
Chipotle Mexican Grill
CMG
$44B
$2.67M 0.81%
220,800
+6,050
+3% +$76.5K
IPXL
22
DELISTED
Impax Laboratories, Inc.
IPXL
$2.65M 0.81%
57,823
+31,580
+120% +$1.5M
MNK
23
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.43M 0.74%
20,656
+2,780
+16% +$343K
NFLX icon
24
Netflix
NFLX
$307B
$2.27M 0.69%
241,500
+4,130
+2% +$34.6K
ANIP icon
25
ANI Pharmaceuticals
ANIP
$1.86B
$2.23M 0.68%
35,864
-14,689
-29% -$874K
1
2 3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, JW Asset Management held 53 positions worth $329M, up 42% from $231M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

JW Asset Management deployed $49.2M of net new capital in Q2 2015, opening 6 new positions and adding to 33 existing holdings. Its largest new stake was Concordia International Corp. Common Stock: 557,500 shares worth $40.2M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 70% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lannett Company, Inc., an estimated $5.63M trimmed.

  • JW Asset Management's largest Q2 2015 buy was Concordia International Corp. Common Stock: 557,500 shares worth $40.2M.
  • JW Asset Management added most to QLT Inc in Q2 2015, an estimated $6.07M increase.
  • JW Asset Management's biggest Q2 2015 reduction was Lannett Company, Inc., cutting an estimated $5.63M.
  • JW Asset Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $3.82M.
  • JW Asset Management's ten largest holdings make up 74% of its $329M portfolio in Q2 2015.
  • JW Asset Management opened 6 new positions and closed 5 in Q2 2015.
  • JW Asset Management's portfolio value rose 42% quarter-over-quarter to $329M.

Based on JW Asset Management's 13F filing for Q2 2015, filed 10 Aug 2015.